Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Exchange Rate Effect (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Exchange Rate Effect for 16 consecutive years, with $42392.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect rose 313.86% year-over-year to $42392.0, compared with a TTM value of -$66842.0 through Sep 2025, down 237.98%, and an annual FY2024 reading of -$66232.0, down 307.46% over the prior year.
  • Exchange Rate Effect was $42392.0 for Q3 2025 at China Pharma Holdings, up from -$39627.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $50439.0 in Q4 2023 and bottomed at -$153626.0 in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$15417.1, with a median of -$4092.0 recorded in 2021.
  • Peak annual rise in Exchange Rate Effect hit 1283.72% in 2022, while the deepest fall reached 3654.3% in 2022.
  • Year by year, Exchange Rate Effect stood at -$14578.0 in 2021, then soared by 126.57% to $3874.0 in 2022, then soared by 1201.99% to $50439.0 in 2023, then crashed by 227.35% to -$64236.0 in 2024, then surged by 165.99% to $42392.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for CPHI at $42392.0 in Q3 2025, -$39627.0 in Q2 2025, and -$5371.0 in Q1 2025.